Future drug discovery in renin-angiotensin-aldosterone system intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Future drug discovery in renin-angiotensin-aldosterone system intervention

Published:2017-06-09 Issue: Volume: Page:1-22
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Tamargo Maria¹,Tamargo Juan²

Affiliation:

1. Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERCV, Madrid, Spain

2. Department of Pharmacology, School of Medicine, University Complutense, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERCV, Madrid, Spain

Funder

Instituto de Salud Carlos III

Fundación del BBVA

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1335301

Reference193 articles.

1. Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy

2. The intracrine renin–angiotensin system

3. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

4. Key developments in renin–angiotensin–aldosterone system inhibition

5. New Antihypertensive Drugs Under Development

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current understanding of the link between angiotensin-converting enzyme and pain perception;Drug Discovery Today;2024-09

2. Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors;Scientific Reports;2024-07-10

3. Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety;Frontiers in Immunology;2023-01-24

4. A New Perspective on the Renin-Angiotensin System;Diagnostics;2022-12-21

5. Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway;Frontiers in Pharmacology;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3